Dr. Jaslow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Centennial Blvd
Bldg 1
Voorhees, NJ 08043Phone+1 856-632-2667Fax+1 856-735-6478
Summary
- I am a board certified medical oncologist specializing in breast cancer/high risk/clinical genetics. I completed my medical training including both medical school and my internship and residency at The Mount Sinai Hospital, NY/NY and my Hematology-Oncology Fellowship at The New York Hospital-Weill Cornell Medical Center, NY/NY. I treat all types of breast cancer including early stage, metastatic, male breast Ca, inflammatory. I also have interest and experience in clinical trial management.
Education & Training
- New York-Presbyterian HospitalFellowship, 1999 - 2002
- Icahn School of Medicine at Mount SinaiResidency, 1996 - 1999
- Icahn School of Medicine at Mount SinaiClass of 1996
- Duke UniversityBS, Psychology/Biologic Basis of Behavior, Cum Laude, 1988 - 1992
Certifications & Licensure
- NJ State Medical License 2017 - 2025
- PA State Medical License 2002 - 2024
- DE State Medical License 2017 - 2023
- NY State Medical License 1997 - 2002
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 31 citationsAssociation of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.Zhong Ye, Chun Wang, Shaogui Wan, Zhaomei Mu, Zhenchao Zhang
European Journal of Cancer. 2019-01-01 - 18 citationsImpact of Oncotype DX on Treatment Decisions in ER‐Positive, Node‐Negative Breast Cancer with Histologic CorrelationJulianne R. Biroschak, Gordon F. Schwartz, Juan P. Palazzo, Adam D. Toll, Kristin Brill
The Breast Journal. 2013-05-01 - 107 citationsp53 Overexpression as a Marker of Poor Prognosis in Mantle Cell Lymphomas With t(11; 14)(q13;q32)Diane C. Louie, Kenneth Offit, R. Jaslow, Nasser Z. Parsa, Vundavalli V. Murty
Blood. 1995-10-15
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: